VC
BMY icon

Veracity Capital’s Bristol-Myers Squibb BMY Stock Holding History

Veracity Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,280
Closed -$239K – 239
2020
Q1 		$239K Buy
4,280
+1,124
+36% +$68.7K 0.07% 173
2019
Q4 		$203K Buy
+3,156
New +$181K 0.05% 222

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Veracity Capital's BMY Position: Q2 2020 in Review

Veracity Capital sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 4,280 shares — an estimated $239K sold.

Veracity Capital first reported a position in BMY in Q4 2019 and held it in 2 quarters. The position peaked at $239K in Q1 2020. 2,189 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • Veracity Capital reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
  • Veracity Capital sold 4,280 Bristol-Myers Squibb shares in Q2 2020, an estimated $239K.
  • Veracity Capital first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 2 quarters.
  • Veracity Capital's Bristol-Myers Squibb position peaked at $239K in Q1 2020.
  • 2,189 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Veracity Capital's 13F filing for Q2 2020, filed 13 Jul 2020.